Revision Skincare
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Revision Skincare sits in the top decile of US sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count).
Revision Skincare: 18 sponsored US clinical trials, none currently recruiting.
Revision Skincare sponsors 18 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 18 completed. The most-studied condition in this pipeline is Fine Lines, with 4 trials.
Top-decile sponsor footprint
Revision Skincare ranks in the top decile of sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
18 of 18 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
18 total, page 1 of 1
A 4-week Study Investigating Two Targeted Brightening Serum (A and B) Versus 4% Hydroquinone in Women With Mild to Severe Full-face Hyperpigmentation
NCT07644871
A 16-week Clinical Study Investigating a Dark Spot Corrector Serum in Women With Moderate Discrete Hyperpigmentation
NCT07468175
Evaluation of the Safety and Tolerability of a Brightening Treatment Paired With a Skincare Regimen
NCT07501000
Efficacy and Tolerability of a Scalp Serum
NCT07500623
Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation
NCT06366503
Clinical Case Study Evaluating the Efficacy and Tolerability of a Topical Facial Treatment on Healthy Females with Fitzpatrick Skin Types V and VI
NCT06633731
A Twelve Week Clinical Study to Evaluate the Efficacy and Tolerability of a Sunscreen Moisturizer SPF 50+
NCT06148558
Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With a Radiofrequency Microneedling for Facial Rejuvenation
NCT06157853
A Clinical Study Evaluating the Efficacy and Tolerability of a Topical Facial Treatment For Facial Rejuvenation
NCT06629792
A 12 Week Study to Evaluate the Efficacy of an Eye Cream
NCT05807620
Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With a Hybrid-Fractional Laser for Facial Rejuvenation
NCT06436261
A Clinical Study to Evaluate the Long-Term Efficacy and Tolerability of a Daily Anti-Aging Daily Serum
NCT05514782
A Multi-Center, Open-label Study Evaluate the Efficacy and Tolerability of a Dual Skincare Regimen Treatment for Facial Hyperpigmentation and Photodamaged Skin in Patients Exposed to Extrinsic Factors of Aging
NCT05423873
A Clinical Study to Evaluate the Efficacy of an Anti-Aging Serum
NCT05271136
An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream
NCT04911374
Investigation of the Efficacy and Tolerability of a Cosmetic Product With Onabotulinumtoxin A in the Treatment of Facial Lines
NCT05089851
A Clinical Study to Evaluate Efficacy and Safety of a Cosmetic Product in the Treatment of Facial Lines
NCT04545970
A Clinical Study to Evaluate Efficacy and Tolerability of a Cosmetic Product for Arm Firming
NCT04065035
Therapeutic Areas
How the Revision Skincare archive is shaped
18 indexed studies, none listed as recruiting (0% open); 18 completed (100%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Fine Lines (4 trials), 5 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Revision Skincare: archived-pipeline peers nationwide
Peers matched on 18 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Revision Skincare sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 18 archived trials
- ADC Therapeutics S.A. · 18 trials · 11% recruiting
- Akros Pharma · 18 trials · 0% recruiting
- AO Clinical Investigation and Publishing Documentation · 18 trials · 0% recruiting
- AO Innovation Translation Center · 18 trials · 33% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Revision Skincare page
18 registered trials is a research-attention snapshot, not an endorsement of Revision Skincare or any single study.
- None of Revision Skincare's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Fine Lines is the condition Revision Skincare studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Fine Lines trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Revision Skincare pipeline card: 18 registered trials from official public datasets.Report a data error.